Suppr超能文献

相似文献

1
Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension.
Hypertension. 2016 Jul;68(1):227-35. doi: 10.1161/HYPERTENSIONAHA.116.07232. Epub 2016 May 9.
2
Role of Chemoreceptor Activation in Hemodynamic Responses to Electrical Stimulation of the Carotid Sinus in Conscious Rats.
Hypertension. 2015 Sep;66(3):598-603. doi: 10.1161/HYPERTENSIONAHA.115.05316. Epub 2015 Jul 20.
3
Systemic and renal-specific sympathoinhibition in obesity hypertension.
Hypertension. 2012 Feb;59(2):331-8. doi: 10.1161/HYPERTENSIONAHA.111.185074. Epub 2011 Dec 19.
4
Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass.
Hypertension. 2016 Dec;68(6):1400-1406. doi: 10.1161/HYPERTENSIONAHA.116.08293. Epub 2016 Oct 24.
6
Selective denervation of the aortic and carotid baroreceptors in rats.
Exp Physiol. 2019 Sep;104(9):1335-1342. doi: 10.1113/EP087764. Epub 2019 Jul 7.
7
Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
Hypertension. 2015 Jun;65(6):1217-22. doi: 10.1161/HYPERTENSIONAHA.114.04354. Epub 2015 May 4.
8
Baroreceptor and chemoreceptor contributions to the hypertensive response to bilateral carotid occlusion in conscious mice.
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1990-5. doi: 10.1152/ajpheart.00315.2010. Epub 2010 Sep 17.
10
Effect of baroreceptor activity on ventilatory response to chemoreceptor stimulation.
J Appl Physiol. 1975 Sep;39(3):411-6. doi: 10.1152/jappl.1975.39.3.411.

引用本文的文献

1
Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms.
Clin Kidney J. 2023 Nov 13;17(1):sfad282. doi: 10.1093/ckj/sfad282. eCollection 2024 Jan.
2
Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options.
J Am Heart Assoc. 2024 Jan 2;13(1):e032277. doi: 10.1161/JAHA.123.032277. Epub 2023 Dec 29.
3
Blood Pressure Regulation by the Carotid Sinus Nerve: Clinical Implications for Carotid Body Neuromodulation.
Front Neurosci. 2022 Jan 10;15:725751. doi: 10.3389/fnins.2021.725751. eCollection 2021.
4
In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension.
PLoS One. 2021 Nov 18;16(11):e0259917. doi: 10.1371/journal.pone.0259917. eCollection 2021.
5
Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.
Cell Metab. 2021 Jun 1;33(6):1155-1170.e10. doi: 10.1016/j.cmet.2021.04.007. Epub 2021 May 4.
6
Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
Cardiovasc Res. 2021 Jul 7;117(8):1859-1876. doi: 10.1093/cvr/cvaa336.
7
Lifestyle interventions for the prevention and treatment of hypertension.
Nat Rev Cardiol. 2021 Apr;18(4):251-275. doi: 10.1038/s41569-020-00437-9. Epub 2020 Oct 9.
8
Leptin Induces Hypertension Acting on Transient Receptor Potential Melastatin 7 Channel in the Carotid Body.
Circ Res. 2019 Nov 8;125(11):989-1002. doi: 10.1161/CIRCRESAHA.119.315338. Epub 2019 Sep 23.
9
Obesity, kidney dysfunction and hypertension: mechanistic links.
Nat Rev Nephrol. 2019 Jun;15(6):367-385. doi: 10.1038/s41581-019-0145-4.
10
Device-Based Neuromodulation for Resistant Hypertension Therapy.
Circ Res. 2019 Mar 29;124(7):1071-1093. doi: 10.1161/CIRCRESAHA.118.313221.

本文引用的文献

2
Role of Chemoreceptor Activation in Hemodynamic Responses to Electrical Stimulation of the Carotid Sinus in Conscious Rats.
Hypertension. 2015 Sep;66(3):598-603. doi: 10.1161/HYPERTENSIONAHA.115.05316. Epub 2015 Jul 20.
3
Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
Hypertension. 2015 Jun;65(6):1217-22. doi: 10.1161/HYPERTENSIONAHA.114.04354. Epub 2015 May 4.
4
Global- and renal-specific sympathoinhibition in aldosterone hypertension.
Hypertension. 2015 Jun;65(6):1223-30. doi: 10.1161/HYPERTENSIONAHA.115.05155. Epub 2015 Apr 20.
5
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
Circ Res. 2015 Mar 13;116(6):991-1006. doi: 10.1161/CIRCRESAHA.116.305697.
6
The sympathetic nervous system alterations in human hypertension.
Circ Res. 2015 Mar 13;116(6):976-90. doi: 10.1161/CIRCRESAHA.116.303604.
7
Baroreflex activation: from mechanisms to therapy for cardiovascular disease.
Curr Hypertens Rep. 2014 Aug;16(8):453. doi: 10.1007/s11906-014-0453-9.
8
Baroreflex activation therapy in hypertension.
J Hum Hypertens. 2014 Aug;28(8):469-74. doi: 10.1038/jhh.2013.139. Epub 2014 Jan 30.
9
Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation.
Respir Res. 2013 Nov 20;14(1):132. doi: 10.1186/1465-9921-14-132.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验